CMC in the Therapeutic Development Process with Olga Paley of Takeda
Feb
13
2025
Feb
13
2025
Description
Dr. Olga Paley, Director of Bioprocess Development at Takeda, will discuss “Advancing Takeda’s Bioprocessing Platforms in Support of Clinical and Commercial Drug Supply” about the Chemistry, Manufacturing and Controls (CMC) part of the therapeutic development process. Paley is a UT alum, earning her Chemical Engineering Ph.D. in 2014.
This talk is part of a continuing series from Texas Biologics covering cutting-edge technology developments across a range of research fields.
Other Events in This Series
Nov
7
2024
Rare disease therapeutics with Jack Borrok of Amgen
Texas Biologics presents industry experts who are leading biotech and biologic therapy R&D and commercialization.
9:30 am – 11:00 am • In Person
Speaker(s): Jack Borrock
Nov
19
2024
Cell medicines with Mark Pogson of Regeneron
Texas Biologics presents industry experts who are leading biotech and biologic therapy R&D and commercialization.
9:30 am – 11:00 am • In Person
Speaker(s): Mark Pogson